| Financial Year |
March 31 2023 |
| Monetary Funds |
668,545,940.68 |
| Held-for-trading Financial Assets |
81,538,024.21 |
| Notes Receivable |
-- |
| Accounts Receivable |
95,439,670.47 |
| Advances to Suppliers |
2,995,844.94 |
| Other Receivables |
324,106.80 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
71,051,585.88 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
-- |
| Total Current Assets |
927,787,711.49 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
-- |
| Investment Properties |
1,468,539.78 |
| Fixed Assetes |
96,484,824.81 |
| Under-construction Projects |
6,818,463.17 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
10,287,503.87 |
| R&D expenses |
-- |
| Goodwill |
-- |
| Long-Term Deferred and Prepaid Expenses |
219,898.74 |
| Deferred Income Tax Assets |
3,246,730.03 |
| Other Non-Current Assets |
260,000.00 |
| Sub-Total of Non-Current Assets |
123,632,912.14 |
| Total Assets |
1,051,420,623.63 |
| Short-Term Loans |
-- |
| Trading Financial liabilities |
-- |
| Notes Payable |
64,746,518.71 |
| Accounts Payable |
61,782,423.01 |
| Accounts Received In Advance |
1,353,378.74 |
| Employee Compensation Payable |
7,347,723.26 |
| Taxes Payable |
3,645,917.94 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
877,496.10 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
370,028.59 |
| Other Current Liabilities |
76,161.31 |
| Sub-Total of Current Liabilities |
145,211,831.88 |
| Long-term Loans |
-- |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
5,898,562.54 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
16,284,106.40 |
| Total Liabilities |
161,495,938.28 |
| Paid-In Capital(Or Share Stock) |
80,000,000.00 |
| Capital Surplus |
551,329,121.13 |
| Surplus Reserve |
25,648,339.30 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
232,947,224.92 |
| Minority Stockholder's Interest |
-- |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
889,924,685.35 |
| Owner's Equity（Stockholder's Equity） |
889,924,685.35 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
1,051,420,623.63 |
